Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

ENHANCEMENT OF THE RENAL EXCRETION OF CESIUM-137 IN RATS TREATED WITH ACETAZOLAMIDE AND RELATED COMPOUNDS

Journal Article · · J. Pharmacol. Exptl. Therap.
OSTI ID:4051517

Since Cs and K are closely similar in physicochemical properties and therefore handled similarly physiologically, agents effective in increasing K excretion were tested for ability to increase excretion of /sup 137/Cs, a major fallout radionuclide. In rats the renal excretion of /sup 137/Cs was shown to be increased by carbonic anhydrase inhibitors (acetazolamide, ethoxzolamide), inhibitors of the H/sup +/ exchange system (maleate) and materials producing hyperchloremic acidosis (ammonium chloride). The results indicate that Cs/sup +/ substitutes for K/sup +/ in the H/sup +/ exchange system. Metalluride blocked the effect of acetazolamide on /sup 137/Cs excretion without influence on urine volume and pH. This indicates that acetazolamide increases the urinary excretion of /sup 137/Cs by increasing its secretion through the renal tubule in the same manner as it increases excretion of K. Metabolic acidosis nullified the effect of acetazolamide on /sup 137/Cs excretion. Rats treated with ammonium chloride and ammonium chloride followed by acetazolamide excreted equal amounts of /sup 137/Cs. Repeated doses of acetazolamide did not increase /sup 137/Cs excretion, which is similar to the influence of the repeated doses of acetazolamide on K excretion. A relation was noted between the activities of the structural analogs of acetazolamide in their inhibition of carbonic anhydrase and their efficacies for increasing the urinary excretion of /sup 137/Cs. Clinical doses of the very active carbonic anhydrase inhibitors, ethoxzolamide and acetazolamide, increased / sup 137/Cs excretion for 6 hours. Chlorothiazide is a weak carbonic anhydrase inhibitor, and large doses increased the /sup 137/Cs excretion only for the first hour. Clinical doses of hydrochlorothiazide, which do not inhibit carbonic anhydrase, did not increase /sup 137/Cs excretion. Maleate increased /sup 137/Cs and bicarbonate in urine for 6 hours. Acetazolamide increased /sup 137/Cs excretion and thereby decreased the retention in the muscle. Chlorothiazide increased /sup 137/Cs excretion during the first hour, but its cumulative effect was to decrease /sup 137/Cs excretion, and thereby favor accumulation of higher concentrations of /sup 137/Cs in the skeletal muscle. These findings indicate that the excretions of /sup 137/Cs and K are controlled by similar renal mechanisms, and the /sup 137/Cs excretion can be influenced effectively by pharmacologic agents. (BBB)

Research Organization:
Vanderbilt Univ., Nashville
NSA Number:
NSA-18-017439
OSTI ID:
4051517
Journal Information:
J. Pharmacol. Exptl. Therap., Journal Name: J. Pharmacol. Exptl. Therap. Vol. Vol: 143
Country of Publication:
Country unknown/Code not available
Language:
English